Articles tagged "Cadaveric organs"

2016 American Transplant Congress
The Immunologic Profile of Brain Death in Humans: A Whole-Body Analysis.
D. Carpenter,^1,2 N. Matsuoka,¹ J. Thome,^1,3 T. Granot,^1,3 C. Gordon,^1,3 B. Kumar,^1,3 T. Senda,^1,3 M. Miron,^1,3 J. Weiner,² A. Griesemer,^1,2 D. Farber.^1,2,3
¹Columbia Center for Translational Immunology, Columbia University Medical Center, New York City, NY; ²Surgery, Columbia University Medical Center, New York City, NY; ³Microbiology and Immunology, Columbia University Medical Center, New York City, NY.
Transplantation outcomes are believed to be influenced by a generalized inflammatory state caused by brain death itself or events in the peri-transplant period. Studies on…
2016 American Transplant Congress
Impact of the Kidney Allocation System with Deceased Donor Kidney Utilization at the DSA Level.
W. Ally,² C. Saunders,¹ K. Brayman,² A. Agarwal.²
¹Lifenet Health, Virginia Beach, VA; ²University of Virginia Health System, Charlottesville, VA.
Background: In December 2014, UNOS implemented broad sweeping changes in the new Kidney Allocation System (KAS). Recent summary reports by UNOS suggest that on a…
2016 American Transplant Congress
Multiorgan Procurement a Learning Tool in General Surgical Resident Education.
J. Bayer, R. Goldstein, G. McKenna, G. Testa, R. Ruiz, T. Anthony, N. Onaca, G. Klintmalm, P. Kim.
Transplant Surgery, Baylor University Medical Center, Dallas, TX.
IntroductionRestricted duty hours and the growing use of minimally invasive techniques, is limiting the open surgical experience for general surgery (GS) residents. Multiorgan procurement (MP)…
2016 American Transplant Congress
Donors with Isolated Anti-HBc (“HBcAb Only”) Antibodies: True Evidence for Past Infection or Laboratory Artifact? Toward a Simple Confirmatory Test for HBcAb.
Y. Chang,^1,3 C. Chinchilla-Reyes,² M. Koss,^1,2 M. Nowicki.^1,2
¹Mendez National Institute of Transplantation Foundation, Los Angeles, CA; ²Viracor-IBT Laboratories, Los Angeles, CA; ³Western University of Health Sciences, Pomona, CA.
Use of organs from donors positive for hepatitis B virus (HBV) markers may safely expand the donor pool. Recently the American Society of Transplantation expert…
2016 American Transplant Congress
Steroid Free Immunosuppression and Clinical Outcomes in Recipients of Deceased Donor Kidney Transplant with Positive Flow Cytometry Crossmatch.
O. Adebiyi, T. Taber, W. Goggins, D. Mishler, M. Yaqub, A. Sharfuddin.
Indiana University, Indianapolis.
Background: Positive flow cytometry crossmatch (FCXM) is considered a high immunologic risk for transplantation. Available studies reporting outcomes in positive FCXM kidney transplants were done…
2016 American Transplant Congress
Utilization of HCV-Positive Donors' Kidneys: Potential Benefits in the Era of Direct Acting Antiviral (DAA) Therapy.
B. Amundsen,¹ M. Sise,² M. Lin,³ H. Deirawan,¹ E. Heher,² B. Kimball,¹ J. Markmann,¹ N. Elias.¹
¹Massachusetts General Hospital, Boston, MA; ²Massachusetts General Hospital, Boston, MA; ³Brigham and Women's Hospital, Boston, MA.
Organ shortage and expanding kidney waiting list fostered utilization of HCV positive donors' organs (HCVD+). HCVD+ kidneys have slightly worse long term outcomes compared with…
2016 American Transplant Congress
Comparing Renal Function After Liver Transplantation: Modified Piggyback versus Conventional Techniques without Venovenous Bypass.
J. Lee, J. Lee, S. Song, J. Lee, S.-K. Kwon, D. Han, M. Ju, G. Choi, J. Choi, M. Kim, S. Kim, D. Joo.
Surgery, Yonsei University College of Medicine, Seoul, Korea.
BackgroundThere are several options available for caval reconstruction in liver transplantation. Prior reports demonstrated that caval reconstruction technique could affect the renal function. However, there…
2016 American Transplant Congress
Quantitative Hepatitis C Virus (HCV) RNA in Plasma and Kidney Tissue in HCV Antibody Positive Donors.
H. Shike,¹ Z. Kadry,² R. Shah,² Y. Imamura,¹ W. Greene,¹ J. Gaspari,¹ T. Riely,¹ H. Nathan,³ R. Hasz,³ A. Jain.¹
¹Surgery, Transplant, Hershey Medical Center, Hershey, PA; ²Pathology, Hershey Medical Center, Hershey, PA; ³OPO, Gift of Life Donor Program, Philadelphia, PA.
Background: Currently HCV antibody positive deceased donors renal allografts are not considered for transplantation in HCV negative recipients. With recent development of anti-HCV therapy, utilization…
2016 American Transplant Congress
Eversion Endarterectomy of the Deceased Donor Renal Artery to Prevent Kidney Discard.
M. Khan, K. Jones, H. El-Hennawy, A. Farney, J. Rogers, G. Orlando, R. Stratta.
Surgery, Wake Forest, Winston-Salem, NC.
Deceased donor (DD) kidneys exhibiting severe atherosclerosis with hard ulcerative occlusive plaque extending into the renal artery (RA) may represent a contraindication to utilization. Limited…
2016 American Transplant Congress
Role of Donor Hemodynamic Trajectory in Determining Graft Survival in Liver Transplantation from Donation After Circulatory Death Donors.
D. Firl, K. Hashimoto, C. O'Rourke, J. Fung, B. Eghtesad.
Cleveland Clinic, Cleveland.
This retrospective study of 87 donation after circulatory death (DCD) liver transplants from 2007-2015 tested the hypothesis that donor hemodynamic trajectory following withdrawal effects graft…